Submission of intimation of reconstitution of Committees.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals Ltd has informed BSE that its Board of Directors, at a meeting held on 30th March 2026, reconstituted three key board committees with effect from the same date. The Audit Committee will be chaired by Janardhan Das Kabra (Non-Executive Independent Director) with Mayuri Baidya and Sridevi Belide as members. The Nomination & Remuneration Committee has the same composition. The Stakeholders Relationship Committee will be chaired by Sridevi Belide (Non-Executive Non-Independent Director) with Janardhan Das Kabra and Mayuri Baidya as members. The board meeting concluded at 6:30 PM. The filing is made under Regulation 30 of SEBI LODR Regulations, 2015.
This is a routine corporate governance compliance update with no material impact on the company's financials or stock price. It simply reshuffles the composition of mandatory board committees, ensuring compliance with SEBI listing requirements.